Alex Sverdlov

Alex Sverdlov is an accomplished statistical scientist with extensive experience in the pharmaceutical industry. Currently serving as a Senior Director at Novartis since October 2016, Alex leads statistical activities for early clinical development in Neuroscience. Previous roles include Associate Director of Biostatistics at EMD Serono, where Alex led projects in immunology and neurodegenerative diseases, and various positions at Novartis focusing on diabetes and metabolism. Earlier experience includes serving as Senior Research Biostatistician at Bristol-Myers Squibb, contributing to neuroscience trials, and internships at Merck and Johnson & Johnson. Alex holds a Ph.D. in Information Technology/Statistical Science from George Mason University, a Master’s in Statistics from the University of Maryland Baltimore County, and a Bachelor’s in Applied Mathematics from V. N. Karazin Kharkiv National University.